M&A ADVISORY
M&A advisory firms
Deal leads · sector heads
A defensible workstream to add to your commercial due diligence output.
The regulatory workstream that tells a deal team what a consumer brand can actually sell, where, and at what cost to fix the gaps — before the deal closes.
A defensible read on whether a target can maintain market access where your thesis assumes it — so you preserve revenue streams and preserve the value of your transactions.
| SKU / brand | US | EU | UK | KR | GCC |
|---|---|---|---|---|---|
| Retinol Night Serum | |||||
| SPF 50 Facial Fluid | |||||
| Marine Collagen Sachets | |||||
| Kids' Multivitamin Gummies | |||||
| Aroma Diffuser Device |
Standard diligence flags regulatory exposure, then hands the product question to legal counsel — whose remit is licensing and contracts, not whether each SKU can ship. Left unverified, it resurfaces after close: a delayed launch, a renegotiated warranty, a valuation you didn't earn.
A generic line item, left to counsel — a caveat, not a number.
Scored per product, per market — with a costed figure to close every gap.
The deal-side associate, principal or partner building an IC pack — not a regulatory affairs manager planning a launch. Three buyers commission it.
A defensible workstream to add to your commercial due diligence output.
A clear compliance risk position for your client — not a caveat in a legal appendix.
Market-entry risk priced into the deal before it's signed.
A pre-close, product-level read on what a target can sell, where, and what it costs to close each gap — scored for your IC pack, not written as a legal opinion.
This is the engagement boundary — exactly what you get, and where it ends. Everything on the right stays with your legal counsel and other diligence workstreams.
Every brand and SKU, scored pass / flag / gap across your target markets.
A modelled figure to close each gap — the number behind a purchase price adjustment.
A written, defensible summary — built to inform representations and warranties.
Red flags ranked by revenue impact and timeline — your triage list and your leverage.
Your SKU range mapped to the deal's geographic thesis.
Market-by-market pass / flag / gap, prioritised based on strategic importance.
Matrix, memo and register — ahead of IC or signing.
The scored read on what a target can sell and what each gap costs.
Flagged gaps become a costed remediation plan — same team, no handoff.
Two stages, not three. The diagnostic feeds straight into execution — no separate bridge offering, no handoff to a team that wasn't in the data room with you.
Each vertical already has its own siloed specialist. Acquire a diversified portfolio and you're assembling a different one per category.
It's the gap between the revenue your model assumes and what the target can actually book. If a SKU isn't authorised to sell in a market you're counting on, that's exposure — and we verify it, market by market, before close.
Counsel covers licensing, litigation, contracts, antitrust, AML and privacy. We cover product-level market access — whether each SKU can be authorised, labelled and certified to sell. Complementary, not overlapping.
Running it pre-close means they don't have to. Findings inform representations and warranties, closing conditions and price up front; if the deal proceeds, the gaps become a costed remediation plan under Full Product Compliance.
Seven: cosmetics, supplements, food & beverage, chemicals, electronics, medical devices and general consumer goods. The value is highest on portfolios spanning several.
A diligence sprint: intake in two days, assessment by day seven, delivery ahead of IC or signing — seamlessly integrated into your M&A strategy, not run alongside it.
Scoped per engagement by the number of brands and target markets in your thesis — not a percentage of deal value. Share the portfolio and geographies, and we'll scope to your timeline.
Share the portfolio and the geographies your thesis assumes. We'll scope a review to your diligence timeline.